Barclays’s Thrive Acquisition Corporation Class A ordinary shares THAC Stock Holding History

Barclays’s Portfolio THAC Stock Details THAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-152,914	Closed	-$1.58M	–	5550
2022 Q4	$1.58M	Sell	152,914 -107,727	-41%	-$1.1M	﹤0.01%	2427
2022 Q3	$2.64M	Hold	260,641	–	–	﹤0.01%	1552
2022 Q2	$2.62M	Hold	260,641	–	–	﹤0.01%	1666
2022 Q1	$2.61M	Buy	+260,641	New	+$2.59M	﹤0.01%	1666

Barclays's THAC Position: Q1 2023 in Review

Barclays sold out of Thrive Acquisition Corporation Class A ordinary shares (THAC) in Q1 2023, closing a stake of 152,914 shares — an estimated $1.58M sold.

Barclays first reported a position in THAC in Q1 2022 and held it in 4 quarters. The position peaked at $2.64M in Q3 2022. 0 funds tracked by Wall St. Rank hold THAC as of Q1 2023.

Barclays reported no remaining Thrive Acquisition Corporation Class A ordinary shares position as of Q1 2023 after selling out during the quarter.
Barclays sold 152,914 Thrive Acquisition Corporation Class A ordinary shares shares in Q1 2023, an estimated $1.58M.
Barclays first reported a position in Thrive Acquisition Corporation Class A ordinary shares in Q1 2022 and held it in 4 quarters.
Barclays's Thrive Acquisition Corporation Class A ordinary shares position peaked at $2.64M in Q3 2022.
0 funds tracked by Wall St. Rank held Thrive Acquisition Corporation Class A ordinary shares as of Q1 2023.

Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.